-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Upgrades Imax to Overweight, Raises Price Target to $47

Benzinga·12/15/2025 13:33:50
Listen to the news
JP Morgan analyst David Karnovsky upgrades Imax (NYSE:IMAX) from Neutral to Overweight and raises the price target from $32 to $47.